BSX Stock Analysis: Buy, Sell, or Hold?
BSX - Boston Scientific Corp.
$46.73
0.73 (1.59%)
▲
5d:
+5.6%
30d:
+8.52%
90d:
-18.89%
BUY
MODERATE Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Jul 29, 2026
0d
Smart Money Distribution
None View Scanner →
Strength: 9.5/10
Get Alerted When BSX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: BSX shows positive signals but monitor for confirmation. Market pricing in 10.0% decline. Moderate conviction.
💡 BUY OPPORTUNITY: BSX shows positive signals but monitor for confirmation. Market pricing in 10.0% decline. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$80.34
Based on 4.7% avg growth
INTRINSIC VALUE TODAY
$49.89
6.3% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 18.4x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: BSX is currently trading at $46.73, which is considered extended relative to its 30-day fair value range of $43.36 to $45.52. From a valuation perspective, the stock is trading at a discount (Forward PE: 13.4) compared to its historical average (18.4). Remarkably, the market is currently pricing in an annual earnings decline of 10.0% over the next few years. This pessimistic expectation contrasts with the company's recent 15.1% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, BSX is in a strong downtrend. The price is approaching resistance at $47.16. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: BSX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $64.28 (+37.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, BSX is in a strong downtrend. The price is approaching resistance at $47.16. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: BSX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $64.28 (+37.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$43.36 -
$45.52
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
61.9%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 37.5% below Wall St target ($64.28)
Trading Range Analysis
30-Day Trading Range
$43.36 -
$45.52
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$42.50
Resistance Level
$47.16
Current Trend
Strong Downtrend
Technical data as of
Jul 31, 2026
Fundamental Context
Forward P/E (Next Year Est.)
13.43
Wall Street Target
$64.28
(+37.5%)
Revenue Growth (YoY)
7.5%
Earnings Growth (YoY)
15.1%
Profit Margin
17.5%
Valuation Discount vs History
-10.0% cheaper
PE vs Historical
13.4 vs 18.4
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-10.0%
(market-implied from PE analysis)
1-Year Target
$42.06
(-10%)
2-Year Target
$37.85
(-19%)
3-Year Target
$34.07
(-27%)
3-Yr Target (if PE normalizes)
(PE: 13→18)
$46.66
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.7, Growth: 5.3%)
$84.11
(+80%)
Base:
(SPY PE: 13.4, Growth: 5.3%)
$54.50
(+17%)
Bear:
(PE: 11.4, Growth: 5.3%)
$46.33
(-1%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (19x PE), but valuation improves significantly next year (13x PE) as earnings recover.
Trailing PE: 18.62 | Current EPS (TTM): $2.47
Bull Case
$71.27
(+53%)
Analyst growth 40.8%, PE expands to 20.5
Base Case
$64.79
(+39%)
Market implied 40.8%, PE stable at 18.6
Bear Case
$31.28
(-33%)
Severe decline -20.0%, PE contracts to 15.8
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 13.4 to 18.4
Stabilization Target:
$64.01
(+37.0%)
PE Expansion Potential:
+37.0%
Share & Embed Analysis
Last updated: August 02, 2026 11:48 AM ET
Data refreshes hourly during market hours. Next update: 12:48 PM
Data refreshes hourly during market hours. Next update: 12:48 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BSX showing a specific setup today?
Insider Activity (6 Months)
3
Buys
4
Sells
Net
INSIDERS SELLING
Recent Transactions
Ro Khanna
BUY
2026-03-30
Ro Khanna
SELL
2026-03-23
Ro Khanna
SELL
2026-02-24
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SYK
Stryker Corporation |
BUY
32 analysts |
$384 | 51 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$118 | 52 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$98 | 57 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$236 | 51 HOLD |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$101 | 52 HOLD |
Advanced BSX Option Strategies
Professional options setups generated by AI based on today's BSX price and gamma walls.
